Cyberonics (CYBX) Jumps on Lazard Upgrade
Tweet
Share
E-mailGet Alerts CYBX Hot Sheet
Price: $69.95 --0%
Rating Summary:
6 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 22 | New: 45
Rating Summary:
6 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 22 | New: 45
Join SI Premium – FREE
Shares of Cyberonics (Nasdaq: CYBX) are surging today on the back of an upgrade over at Lazard Capital Markets. Cyberonics most recently traded at $16.43, up $2.06, or 14% from yesterday's close.
Lazard raised its investment rating on Cyberonics from Hold to Buy.
Cyberonics, Inc., a neuromodulation company, engages in the design, development, manufacture, and marketing of implantable medical devices that provide vagus nerve stimulation (VNS) therapy for the treatment of epilepsy and treatment-resistant depression.
Lazard raised its investment rating on Cyberonics from Hold to Buy.
Cyberonics, Inc., a neuromodulation company, engages in the design, development, manufacture, and marketing of implantable medical devices that provide vagus nerve stimulation (VNS) therapy for the treatment of epilepsy and treatment-resistant depression.
You May Also Be Interested In
- Verizon planning new round of layoffs this week - Barron’s
- Guggenheim Upgrades Digital Realty Trust (DLR) to Buy
- Susquehanna Upgrades CSX (CSX) to Positive
Create E-mail Alert Related Categories
Insiders' Blog, UpgradesRelated Entities
LazardSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
